作者
Wen-Hung Chung, Wan-Chun Chang, Yun-Shien Lee, Ying-Ying Wu, Chih-Hsun Yang, Hsin-Chun Ho, Ming-Jing Chen, Jing-Yi Lin, Rosaline Chung-Yee Hui, Ji-Chen Ho, Wei-Ming Wu, Ting-Jui Chen, Tony Wu, Yih-Ru Wu, Mo-Song Hsih, Po-Hsun Tu, Chen-Nen Chang, Chien-Ning Hsu, Tsu-Lan Wu, Siew-Eng Choon, Chao-Kai Hsu, Der-Yuan Chen, Chin-San Liu, Ching-Yuang Lin, Nahoko Kaniwa, Yoshiro Saito, Yukitoshi Takahashi, Ryosuke Nakamura, Hiroaki Azukizawa, Yongyong Shi, Tzu-Hao Wang, Shiow-Shuh Chuang, Shih-Feng Tsai, Chee-Jen Chang, Yu-Sun Chang, Shuen-Iu Hung, Taiwan Severe Cutaneous Adverse Reaction Consortium, Japan Pharmacogenomics Data Science Consortium
发表日期
2014/8/6
期刊
Jama
卷号
312
期号
5
页码范围
525-534
出版商
American Medical Association
简介
Importance
The antiepileptic drug phenytoin can cause cutaneous adverse reactions, ranging from maculopapular exanthema to severe cutaneous adverse reactions, which include drug reactions with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The pharmacogenomic basis of phenytoin-related severe cutaneous adverse reactions remains unknown.
Objective
To investigate the genetic factors associated with phenytoin-related severe cutaneous adverse reactions.
Design, Setting, and Participants
Case-control study conducted in 2002-2014 among 105 cases with phenytoin-related severe cutaneous adverse reactions (n=61 Stevens-Johnson syndrome/toxic epidermal necrolysis and n=44 drug reactions with eosinophilia and systemic symptoms), 78 cases with maculopapular exanthema, 130 phenytoin-tolerant control participants, and 3655 population controls …
引用总数
20142015201620172018201920202021202220232024731254335473334201614